Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
National CineMedia Inc is an advertising agencies business based in the US. National CineMedia shares (NCMI) are listed on the NASDAQ and all prices are listed in US Dollars. National CineMedia employs 418 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Guided Investing
Our top pick for
Experienced Investors
| Latest market close | $3.56 |
|---|---|
| 52-week range | $1.70 - $5.87 |
| 50-day moving average | $3.10 |
| 200-day moving average | $3.94 |
| Wall St. target price | $5.63 |
| PE ratio | N/A |
| Dividend yield | $0.22 (6.15%) |
| Earnings per share (TTM) | $-1.15 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $3.56 from 2021-10-15
| 1 week (2021-10-08) | -5.57% |
|---|---|
| 1 month (2021-09-17) | 21.50% |
| 3 months (2021-07-17) | -17.78% |
| 6 months (2021-04-16) | -18.16% |
| 1 year (2020-10-16) | 61.09% |
|---|---|
| 2 years (2019-10-16) | -57.44% |
| 3 years (2018-10-16) | 9.54 |
| 5 years (2016-10-14) | 14.18 |
Valuing National CineMedia stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of National CineMedia's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
National CineMedia's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $38.9 million.
The EBITDA is a measure of a National CineMedia's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $41.1 million |
|---|---|
| Gross profit TTM | $46.9 million |
| Return on assets TTM | -6.23% |
| Return on equity TTM | 0% |
| Profit margin | -218.98% |
| Book value | $-4.96 |
| Market capitalisation | $288.6 million |
TTM: trailing 12 months
There are currently 3.7 million National CineMedia shares held short by investors – that's known as National CineMedia's "short interest". This figure is 5% down from 3.9 million last month.
There are a few different ways that this level of interest in shorting National CineMedia shares can be evaluated.
National CineMedia's "short interest ratio" (SIR) is the quantity of National CineMedia shares currently shorted divided by the average quantity of National CineMedia shares traded daily (recently around 986450.67024129). National CineMedia's SIR currently stands at 3.73. In other words for every 100,000 National CineMedia shares traded daily on the market, roughly 3730 shares are currently held short.
However National CineMedia's short interest can also be evaluated against the total number of National CineMedia shares, or, against the total number of tradable National CineMedia shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case National CineMedia's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 National CineMedia shares in existence, roughly 50 shares are currently held short) or 0.0596% of the tradable shares (for every 100,000 tradable National CineMedia shares, roughly 60 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against National CineMedia.
Find out more about how you can short National CineMedia stock.
We're not expecting National CineMedia to pay a dividend over the next 12 months.
Over the last 12 months, National CineMedia's shares have ranged in value from as little as $1.7003 up to $5.8668. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while National CineMedia's is 1.5725. This would suggest that National CineMedia's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
National CineMedia, Inc. , through its subsidiary, National CineMedia, LLC, operates cinema advertising network in North America. The company engages in the sale of advertising to national, regional, and local businesses in Noovie, a cinema advertising and entertainment pre-show seen on movie screens; and sells advertising on its Lobby Entertainment Network, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theatre lobbies. It is also involved in the sale of online and mobile advertising through its Noovie Audience Accelerator product, as well as a suite of Noovie digital properties, such as Noovie. com, Noovie Shuffle, Noovie Trivia, Name That Movie, and Noovie Arcade to reach entertainment audiences beyond the theater. The company offers its services to third-party theater circuits under long-term network affiliate agreements. National CineMedia, Inc.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.